MYRIAD - VECTRA TESTING BUSINESS
Vectra is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity. It combines those measures to generate an easy-to-understand score, which indicates the severity of RA inflammation and how well current treatments are working. It also can predict potential, future joint damage. This enables the 5,000 practicing rheumatologists in the U.S. to provide targeted treatment and adjust existing treatments to better manage RA symptoms
MYRIAD - VECTRA TESTING BUSINESS
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.myriad.com
Status:
Closed
Similar Organizations
CreaGen
CreaGen is a chemistry-based company that develops innovative medicines based on discovery research.
Official Site Inspections
http://www.myriad.com
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Myriad - Vectra Testing Business" on Search Engine
Myriad - Vectra Testing Business - Crunchbase
2,271,914. Similar Companies 3. Details. Industries. Biotechnology. Medical Device. Pharmaceutical. Headquarters Regions Western US. Operating Status Closed. Company Type For Profit. Vectra is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity.See details»
Labcorp Completes Acquisition Of Myriad Autoimmune’s Vectra Testing ...
Labcorp Completes Acquisition Of Myriad Autoimmune’s Vectra Testing Business. BURLINGTON, N.C., Sept. 13, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including ...See details»
Labcorp to acquire Myriad Autoimmune’s Vectra testing business …
May 3, 2021 The acquisition of the Vectra test and related IP and other assets complements Labcorp’s prior business activity aimed at bolstering its scientific leadership in RA testing and treatment.See details»
Myriad - Vectra Testing Business acquired by LabCorp
May 3, 2021 Overview. Acquired Organization: Myriad - Vectra Testing Business Vectra is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity. Acquiring Organization: LabCorp Labcorp specializes in providing physicians with laboratory tests. Announced Date May 3, 2021. Completed On Date Sep …See details»
Myriad Genetics Completes Sale of Myriad Autoimmune’s Vectra Testing ...
SALT LAKE CITY, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has completed the sale of...See details»
Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business …
May 3, 2021 Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics | Nasdaq. Published. May 3, 2021 6:58AM EDT. Transaction Bolsters Labcorp’s Growing Rheumatology and...See details»
Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business …
May 3, 2021 Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra® rheumatoid arthritis (RA) assay.See details»
Labcorp to Acquire Myriad's Vectra Testing Business for $150M
May 4, 2021 Labcorp acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21; The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfoliosSee details»
Labcorp to acquire Myriad’s Vectra testing business for $150m
May 4, 2021. The Vectra rheumatoid arthritis assay will be added to Labcorp’s in-house products. Credit: Labcorp. Labcorp has signed a definitive agreement to acquire certain operating assets and intellectual property (IP) of Myriad Genetics ’ autoimmune business unit for $150m in cash.See details»
Laboratory of America : Labcorp to Acquire Myriad Autoimmune's Vectra ...
May 4, 2021 The acquisition of the Vectra test and related IP and other assets complements Labcorp's prior business activity aimed at bolstering its scientific leadership in RA testing and treatment. The transaction is expected to close by the end of the third quarter, subject to customary closing conditions and regulatory approvals, including …See details»
Laboratory of America : Labcorp Completes Acquisition of Myriad ...
Sep 14, 2021 BURLINGTON, N.C. - Labcorp (NYSE: LH), a leading global life sciences company, announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics' autoimmune business unit, including the Vectra rheumatoid arthritis (RA) assay. Earlier this year, Labcorp entered into a …See details»
LabCorp Acquires Myriad Autoimmune s Vectra Testing Business
May 3, 2021 Myriad Autoimmune's Vectra Testing Business is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity. It combines those measures to generate an easy-to-understand score, which indicates the severity of RA inflammation and how well current treatments are working.See details»
Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing ...
Sep 13, 2021 Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business. Sep 13, 2021 at 4:35 PM EDT. Download PDF. BURLINGTON, N.C. -- (BUSINESS WIRE)--Sep. 13, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets …See details»
Myriad Autoimmune s Vectra Testing Business - Mergr
Myriad Autoimmune's Vectra Testing Business is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity. It combines those measures to generate an easy-to-understand score, which indicates the severity of RA inflammation and how well current treatments are working.See details»
Myriad - Vectra Testing Business - Tech Stack, Apps
This year, Myriad - Vectra Testing Business is projected to spend $14.4M on IT, according to Aberdeen. UNLOCK PREMIUM DATA WITH DATABOOST . Unlock even more features with Crunchbase Pro. Start Your Free Trial. Vectra is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity.See details»
IQVIA adds to growing lab biz with $198M deal for Myriad contract ...
May 25, 2021 Earlier this month, Myriad announced a deal to sell its Vectra test business to LabCorp for $150 million. Vectra is a rheumatoid arthritis blood test that rheumatologists use to better...See details»
HOME | Neatly Ever After
At Neatly Ever After, we are committed to creating custom organizational systems that target the challenging areas of your home. We leave you with organizational solutions that last and are easily maintained by the whole family. Your customized solution can serve you in any part of your life - from your home, to your business, and even your ...See details»
Water Testing - Warrenton, VA - Joiner Micro Labs
Mon-Fri 9:00am-5:00pm CLOSED – Sat, Sun. 2023 UPCOMING HOLIDAYS September 4, 2023 (Monday) Thanksgiving November 23 & 24 Christmas December 25 & 26 New Year’s Jan 1, 2024See details»
LABCORP COMPLETES ACQUISITION OF MYRIAD AUTOIMMUNE’S VECTRA TESTING ...
LABCORP COMPLETES ACQUISITION OF MYRIAD AUTOIMMUNE’S VECTRA TESTING BUSINESS. BURLINGTON, N.C., Sept. 13, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune …See details»
Smog Test, Emissions Checks & Inspections in Warrenton, Virginia - DMV.ORG
Wilson Automotive Inc. Lists & reviews of smog test, emissions check, and inspection stations in Warrenton, Virginia. Find addresses, hours of operation, phone numbers, & forms of payment.See details»